financetom
Business
financetom
/
Business
/
MeridianLink to Be Bought by Centerbridge Partners for $2.0 Billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MeridianLink to Be Bought by Centerbridge Partners for $2.0 Billion
Aug 11, 2025 5:54 AM

08:27 AM EDT, 08/11/2025 (MT Newswires) -- MeridianLink ( MLNK ) said Monday it has entered into a definitive agreement to be acquired by funds advised by affiliates of Centerbridge Partners for about $2.0 billion.

Under the terms of the deal, MeridianLink ( MLNK ) shareholders will receive $20.00 per share in cash for each share of common stock they own.

After the transaction closes, which is expected to occur this year, MeridianLink ( MLNK ) said it will become a private company.

Shares were up more than 24% in recent premarket activity Monday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform
Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform
Mar 11, 2026
HAIFA, Israel, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Minovia Therapeutics Ltd. (“Minovia” or the “Company”), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases and combat age-related decline, today announced that it has been granted two new U.S. patents that further expand and strengthen its global intellectual property portfolio supporting its proprietary Mitochondrial Augmentation Therapy (MAT) platform. The...
Rithm Capital Launches Preferred Stock Offering
Rithm Capital Launches Preferred Stock Offering
Mar 11, 2026
09:52 AM EST, 01/13/2026 (MT Newswires) -- Rithm Capital ( RITM ) said Tuesday that it has launched an underwritten public offering of series F fixed-rate reset cumulative redeemable preferred stock based on market conditions. The company said it intends to list the preferred stock on the New York Stock Exchange under the symbol RITM PR F, and that terms...
US FDA requests removal of suicide warnings from weight-loss drugs
US FDA requests removal of suicide warnings from weight-loss drugs
Mar 11, 2026
Jan 13 (Reuters) - The U.S. Food ‌and ​Drug Administration on ‍Tuesday requested ⁠companies ⁠to ‌remove ​warnings related to ⁠the potential ‍risk ​of suicidal ideation and ‍behavior from the labeling of ​popular ‍weight-loss drugs of ​the GLP-1 class. ...
Why Is Concentrix Stock Falling Tuesday?
Why Is Concentrix Stock Falling Tuesday?
Mar 11, 2026
Concentrix Corporation stock tumbled after the company reported its fourth-quarter results and issued forward guidance that weighed on investor sentiment. Concentrix ( CNXC ) reported quarterly adjusted earnings of $2.95 per share, which beat the Street estimate of $2.75. Quarterly revenue was $2.553 billion, up by 4.3% year-over-year (Y/Y), above the analyst consensus estimate of $2.539 billion. The quarterly revenue grew...
Copyright 2023-2026 - www.financetom.com All Rights Reserved